Speaker(s): 

Eric Carruth, PhD, Staff Member, Geisinger - has nothing to disclose.

Alyson Evans, MS, CGC, Staff Member, Geisinger - has nothing to disclose.

Moderator(s): 

Juliann Savatt, MS. CGC, Staff Member, Geisinger - has nothing to disclose. 

Melissa Kelly, MS, LCGC, Staff Member, Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

•Describe the mechanism of disease and clinical presentation of arrhythmogenic cardiomyopathy (ACM) 

•Illustrate AMC phenotypic variability through MyCode case examples

•Discuss ongoing research efforts to further characterize ACM phenotype

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Cara McCormick, MPH; Adam Buchanan, MS, MPH, LCGC; Juliann Savatt, MS, LCGC; Melissa Kelly, MS, LCGC and Marc Williams, MD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant.